Phillip Frost - Jul 25, 2022 Form 4 Insider Report for Cocrystal Pharma, Inc. (COCP)

Role
Director
Signature
/s/ Phillip Frost, MD, ET AL
Stock symbol
COCP
Transactions as of
Jul 25, 2022
Transactions value $
$0
Form type
4
Date filed
8/3/2022, 04:03 PM
Previous filing
Jun 22, 2022
Next filing
Aug 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COCP Stock Options (Right to Buy) Award $0 +220K $0.00 220K Jul 25, 2022 Common Stock 220K $0.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options were issued pursuant to the 2015 Equity Incentive Plan and vest as follows: one-half will vest and become exercisable on July 25, 2023 and the remaining half will vest and become exercisable in eight equal quarterly installments on the last day of March, June, September, and December commencing on September 30, 2023, subject to the reporting person continuing to serve as a director of the Company on each applicable vesting date.